Yu Mi Kang
About
Yu Mi Kang is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Cardiology and Cardiovascular Medicine.
According to data from OpenAlex, Yu Mi Kang has authored 67 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Epidemiology and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yu Mi Kang's work include Diabetes Treatment and Management (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers) and Liver Disease Diagnosis and Treatment (8 papers). Yu Mi Kang is often cited by papers focused on Diabetes Treatment and Management (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers) and Liver Disease Diagnosis and Treatment (8 papers). Yu Mi Kang collaborates with scholars based in South Korea, China and United States. Yu Mi Kang's co-authors include Chang Hee Jung, Joong‐Yeol Park, Woo Je Lee, Yun Kyung Cho, Min Jung Lee, Hong‐Kyu Kim, Jenie Yoonoo Hwang, Eun Hee Kim, Jung Eun Jang and Jaechan Leem and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.
In The Last Decade
Yu Mi Kang
63 papers receiving 1.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Yu Mi Kang South Korea | 23 | 553 | 445 | 322 | 312 | 273 | 67 | 1.4k | ||
| Kwang Joon Kim South Korea | 28 | 652 1.2× | 560 1.3× | 348 1.1× | 237 0.8× | 360 1.3× | 99 | 2.1k | ||
| Jiin Ahn South Korea | 25 | 608 1.1× | 838 1.9× | 305 0.9× | 144 0.5× | 280 1.0× | 42 | 1.9k | ||
| Fritz Oberhollenzer Austria | 8 | 664 1.2× | 480 1.1× | 255 0.8× | 199 0.6× | 267 1.0× | 18 | 1.3k | ||
| Sandra O. Hernández‐González Mexico | 11 | 810 1.5× | 601 1.4× | 472 1.5× | 158 0.5× | 248 0.9× | 16 | 1.5k | ||
| María G. Ramos-Zavala Mexico | 9 | 875 1.6× | 603 1.4× | 471 1.5× | 181 0.6× | 234 0.9× | 17 | 1.6k | ||
| Sung Kil Lim South Korea | 23 | 601 1.1× | 448 1.0× | 289 0.9× | 388 1.2× | 383 1.4× | 109 | 1.7k | ||
| You‐Bin Lee South Korea | 23 | 628 1.1× | 459 1.0× | 275 0.9× | 189 0.6× | 407 1.5× | 104 | 1.5k | ||
| Ki‐Chul Sung South Korea | 24 | 796 1.4× | 993 2.2× | 412 1.3× | 202 0.6× | 281 1.0× | 44 | 1.8k | ||
| Grażyna Sypniewska Poland | 21 | 293 0.5× | 304 0.7× | 399 1.2× | 263 0.8× | 358 1.3× | 88 | 1.5k | ||
| Luis E. Simental-Mendía Mexico | 3 | 757 1.4× | 552 1.2× | 472 1.5× | 126 0.4× | 195 0.7× | 6 | 1.4k |
Countries citing papers authored by Yu Mi Kang
Since
Specialization
Citations
This map shows the geographic impact of Yu Mi Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Mi Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Mi Kang more than expected).
Fields of papers citing papers by Yu Mi Kang
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Yu Mi Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Mi Kang. The network helps show where Yu Mi Kang may publish in the future.
Co-authorship network of co-authors of Yu Mi Kang
This figure shows the co-authorship network connecting the top 25 collaborators of Yu Mi Kang. A scholar is included among the top collaborators of Yu Mi Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Mi Kang. Yu Mi Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Lee, Matthew M.Y., Nazim Ghouri, Anoop Misra, et al.. (2025). Comparative Efficacy of Glucagon-Like Peptide 1 Receptor Agonists for Cardiovascular Outcomes in Asian Versus White Populations: Systematic Review and Meta-analysis of Randomized Trials of Populations With or Without Type 2 Diabetes and/or Overweight or Obesity. Diabetes Care. 48(3). 489–493.
2.
Li, Xuehua, Yu Mi Kang, Peng Li, et al.. (2024). Integrating network pharmacology with pharmacological research to elucidate the mechanism of modified Gegen Qinlian Decoction in treating porcine epidemic diarrhea. Scientific Reports. 14(1). 18929–18929.
3.
Li, Qiang, Shiqun Chen, Yu Mi Kang, et al.. (2023). Relationship between stress hyperglycemia and worsening heart failure in patients with significant secondary mitral regurgitation. Atherosclerosis. 394. 117306–117306.
4.
Kang, Yu Mi, Douglas A. Rubinson, Igor Odintsov, et al.. (2023). FRI610 Phosphatidylinositol 3-kinase Inhibition With Alpelisib Is Safe And Effective In Treating Refractory Hypoglycemia Associated With Malignant Insulinoma. Journal of the Endocrine Society. 7(Supplement_1).
5.
Xie, Yun, Yang Zhou, Yu Mi Kang, et al.. (2023). Association Between Systemic Immune Inflammation Level and Poor Prognosis Across Different Glucose Metabolism Status in Coronary Artery Disease Patients. Journal of Inflammation Research. Volume 16. 4031–4042.
6.
Liu, Jin, Yang Zhou, Haozhang Huang, et al.. (2023). Impact of stress hyperglycemia ratio on mortality in patients with critical acute myocardial infarction: insight from american MIMIC-IV and the chinese CIN-II study. Cardiovascular Diabetology. 22(1). 281–281.
7.
Chen, Shiqun, Zhidong Huang, Liling Chen, et al.. (2021). Does Diabetes Mellitus Increase the Short- and Long-Term Mortality in Patients With Critical Acute Myocardial Infarction? Results From American MIMIC-III and Chinese CIN Cohorts. Frontiers in Endocrinology. 12. 797049–797049.
8.
Kang, Yu Mi, et al.. (2021). Factors associated with acute myocardial infarction in older patients after hospitalization with community-acquired pneumonia: a cross-sectional study. BMC Geriatrics. 21(1). 113–113.
9.
Kang, Yu Mi, Chang Hee Jung, Seung‐Hwan Lee, et al.. (2019). Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea. Diabetes & Metabolism Journal. 43(4). 432–432.
10.
Lee, Jiwoo, Yun Kyung Cho, Yu Mi Kang, et al.. (2019). The Impact of NAFLD and Waist Circumference Changes on Diabetes Development in Prediabetes Subjects. Scientific Reports. 9(1). 17258–17258.
11.
Cho, Yun Kyung, Yu Mi Kang, Jee Hee Yoo, et al.. (2018). The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification. Scientific Reports. 8(1). 12004–12004.
12.
Kang, Yu Mi, Chang Hee Jung, Yun Kyung Cho, et al.. (2017). Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population. PLoS ONE. 12(4). e0175762–e0175762.
13.
Kang, Yu Mi, Chang Hee Jung, Yun Kyung Cho, et al.. (2017). Visceral adiposity index predicts the conversion of metabolically healthy obesity to an unhealthy phenotype. PLoS ONE. 12(6). e0179635–e0179635.
14.
Jung, Hye Seung, Yu Mi Kang, Ho Seon Park, et al.. (2016). Senp2 expression was induced by chronic glucose stimulation in INS1 cells, and it was required for the associated induction of Ccnd1 and Mafa. Islets. 8(6). 207–216.
15.
Cho, Yun Kyung, Yu Mi Kang, Jenie Yoonoo Hwang, et al.. (2015). Association between serum gamma-glutamyltransferase and the progression of coronary artery calcification. Atherosclerosis. 243(1). 300–306.
16.
Jung, Chang Hee, Woo Je Lee, Min Jung Lee, et al.. (2015). Association of serum angiopoietin-like protein 2 with carotid intima-media thickness in subjects with type 2 diabetes. Cardiovascular Diabetology. 14(1). 35–35.
17.
Jung, Chang Hee, Min Jung Lee, Yu Mi Kang, et al.. (2015). 2013 ACC/AHA versus 2004 NECP ATP III Guidelines in the Assignment of Statin Treatment in a Korean Population with Subclinical Coronary Atherosclerosis. PLoS ONE. 10(9). e0137478–e0137478.
18.
Jung, Chang Hee, Min Jung Lee, Yu Mi Kang, et al.. (2013). Higher serum bilirubin level as a protective factor for the development of diabetes in healthy Korean men: A 4 year retrospective longitudinal study. Metabolism. 63(1). 87–93.
19.
Kang, Yu Mi, et al.. (2012). Antioxidant and anti-inflammatory effects of Dictyopteris undulata Extracts. 한국생물공학회 학술대회. 211–211.
20.
Lee, Kyung‐Mi, Yu Mi Kang, Kwanghee Kim, et al.. (2011). Differential expression of immune-associated cancer regulatory genes in low- versus high-dose-rate irradiated AKR/J mice. Genomics. 97(6). 358–363.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Kwang Joon Kim Breakdown of academic impact, for papers by Jiin Ahn Breakdown of academic impact, for papers by Fritz Oberhollenzer Breakdown of academic impact, for papers by Sandra O. Hernández‐González Breakdown of academic impact, for papers by María G. Ramos-Zavala Breakdown of academic impact, for papers by Sung Kil Lim Breakdown of academic impact, for papers by You‐Bin Lee Breakdown of academic impact, for papers by Ki‐Chul Sung Breakdown of academic impact, for papers by Grażyna Sypniewska Breakdown of academic impact, for papers by Luis E. Simental-Mendía